KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Receivables - Other (2016 - 2018)

Historic Receivables - Other for Arbutus Biopharma (ABUS) over the last 9 years, with Q1 2018 value amounting to $128000.0.

  • Arbutus Biopharma's Receivables - Other changed 0.0% to $128000.0 in Q1 2018 from the same period last year, while for Mar 2018 it was $128000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $128000.0 for FY2017, which is 0.0% changed from last year.
  • According to the latest figures from Q1 2018, Arbutus Biopharma's Receivables - Other is $128000.0, which was down 0.0% from $128000.0 recorded in Q4 2017.
  • In the past 5 years, Arbutus Biopharma's Receivables - Other registered a high of $538000.0 during Q4 2014, and its lowest value of -$1.1 million during Q1 2015.
  • Its 5-year average for Receivables - Other is $131352.9, with a median of $128000.0 in 2015.
  • Over the last 5 years, Arbutus Biopharma's Receivables - Other had its largest YoY gain of 19868.42% in 2015, and its largest YoY loss of 37330.1% in 2015.
  • Quarter analysis of 5 years shows Arbutus Biopharma's Receivables - Other stood at $538000.0 in 2014, then tumbled by 76.21% to $128000.0 in 2015, then changed by 0.0% to $128000.0 in 2016, then changed by 0.0% to $128000.0 in 2017, then changed by 0.0% to $128000.0 in 2018.
  • Its Receivables - Other stands at $128000.0 for Q1 2018, versus $128000.0 for Q4 2017 and $128000.0 for Q3 2017.